Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study Evaluating Pegylated Interferon Alpha-2b and Nucleos(t)Ide Analogues in Treating Chronic Hepatitis B With or Without Metabolic Dysfunction-Associated Steatotic Liver Disease

NCT07071636 is registered in ClinicalTrials.gov with Shenzhen Third People's Hospital as lead sponsor.

NCT NCT07071636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07071636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study Evaluating Pegylated Interferon Alpha-2b and Nucleos(t)Ide Analogues in Treating Chronic Hepatitis B With or Without Metabolic Dysfunction-Associated Steatotic Liver Disease
Lead sponsor
Shenzhen Third People's Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 15, 2025
Completion date
September 30, 2029
Enrollment
830 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b, metabolic dysfunction-associated steatotic liver disease